Skip to main content
Advertisement

AI Bias Analysis

4 models · Takes ~15 seconds

Stat News

STAT+: Pharmalittle: We’re reading about FDA view on peptide compounding, Iran war hurting trial recruitment, and more

STAT+: Pharmalittle: We’re reading about FDA view on peptide compounding, Iran war hurting trial recruitment, and more
ShareXFacebook

The FDA is moving toward allowing compounding pharmacies to produce injectable peptides that were banned over significant safety concerns

S

Source

Stat News

Read full article at Stat News

Opens original article in a new tab

Advertisement

Related Health Stories

When Shared Decision-Making Becomes Medical Paternalism
MedPage Today

When Shared Decision-Making Becomes Medical Paternalism

(MedPage Today) -- "Why haven't they scheduled your dad for his feeding tube placement? They just want another family conference." I sighed and told my mother we may have to fight. The physicians caring for my father seemed ready to overrule her...

Read more →
Antidepressant Reduces Meth Addiction in Trial
MedPage Today

Antidepressant Reduces Meth Addiction in Trial

(MedPage Today) -- Use of the antidepressant mirtazapine in routine clinical practice reduced methamphetamine use in adults with methamphetamine use disorder, a phase III randomized trial showed. In participants who used methamphetamine a median...

Read more →
Advertisement